4.6 Article

Early Downregulation of p75NTR by Genetic and Pharmacological Approaches Delays the Onset of Motor Deficits and Striatal Dysfunction in Huntington's Disease Mice

Journal

MOLECULAR NEUROBIOLOGY
Volume 56, Issue 2, Pages 935-953

Publisher

SPRINGER
DOI: 10.1007/s12035-018-1126-5

Keywords

Huntington's disease; p75(NTR); TrkB; BDNF; Motor deficits onset; Striatal pathology

Categories

Funding

  1. Ministerio de Ciencia e Innovacion [SAF-2014-57160R, SAF2015-67474-R]
  2. Ministerio de Ciencia e Innovacion (MINECO/FEDER)
  3. Centro de Investigaciones Biomedicas en Red sobre Enfermedades Neurodegenerativas (CIBERNED)
  4. Cure Huntington's Disease Initiative [CHDI A-3468]

Ask authors/readers for more resources

Deficits in striatal brain-derived neurotrophic factor (BDNF) delivery and/or BDNF/tropomyosin receptor kinase B (TrkB) signaling may contribute to neurotrophic support reduction and selective early degeneration of striatal medium spiny neurons in Huntington's disease (HD). Furthermore, we and others have demonstrated that TrkB/p75(NTR) imbalance in vitro increases the vulnerability of striatal neurons to excitotoxic insults and induces corticostriatal synaptic alterations. We have now expanded these studies by analyzing the consequences of BDNF/TrkB/p75(NTR) imbalance in the onset of motor behavior and striatal neuropathology in HD mice. Our findings demonstrate for the first time that the onset of motor coordination abnormalities, in a full-length knock-in HD mouse model (KI), correlates with the reduction of BDNF and TrkB levels, along with an increase in p75(NTR) expression. Genetic normalization of p75(NTR) expression in KI mutant mice delayed the onset of motor deficits and striatal neuropathology, as shown by restored levels of striatal-enriched proteins and dendritic spine density and reduced huntingtin aggregation. We found that the BDNF/TrkB/p75(NTR) imbalance led to abnormal BDNF signaling, manifested as a diminished activation of TrkB-phospholipase C-gamma pathway but upregulation of c-Jun kinase pathway. Moreover, we confirmed the contribution of the proper balance of BDNF/TrkB/p75(NTR) on HD pathology by a pharmacological approach using fingolimod. We observed that chronic infusion of fingolimod normalizes p75(NTR) levels, which is likely to improve motor coordination and striatal neuropathology in HD transgenic mice. We conclude that downregulation of p75(NTR) expression can delay disease progression suggesting that therapeutic approaches aimed to restore the balance between BDNF, TrkB, and p75(NTR) could be promising to prevent motor deficits in HD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available